Corradini Paolo

Full professor
Competition sector



Via Venezian, 1
20133 MILANO

Additional phone numbers
02 23902343
University email address



  • PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBC / P. Dreger, A. Sureda, K.W. Ahn, M. Eapen, C. Litovich, H. Finel, A. Boumendil, A. Gopal, A.F. Herrera, C. Schmid, J.L. Diez-Martin, E. Fuchs, J. Bolaños-Meade, M. Gooptu, M.M. Al Malki, L. Castagna, S.O. Ciurea, A. Dominietto, D. Blaise, F. Ciceri, J. Tischer, P. Corradini, S. Montoto, S. Robinson, Z. Gülbas, M. Hamadani. - In: BLOOD ADVANCES. - ISSN 2473-9529. - 3:3(2019 Feb 12), pp. 360-369.
  • Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party / A. Bazarbachi, A. Boumendil, H. Finel, M. Mohty, L. Castagna, D. Blaise, K.S. Peggs, B. Afanasyev, J.L. Diez-Martin, P. Corradini, D. Michonneau, S. Robinson, G. Gutiérrez García, F. Bonifazi, I. Yakoub-Agha, Z. Gülbas, A. Bloor, J. Delage, A. Esquirol, R. Malladi, C. Scheid, J. El-Cheikh, H. Ghesquières, S. Montoto, P. Dreger, A. Sureda. - In: CANCER. - ISSN 0008-543X. - 125:1(2019 Jan), pp. 90-98. ((Intervento presentato al 14. convegno International Conference on Malignant Lymphoma : June, 14th - 17th tenutosi a Lugano nel 2017.
  • Integration of Transcriptional and Mutational Data Simplifies the Stratification of Peripheral T-Cell Lymphoma / F. Maura, L. Agnelli, D. Leongamornlert, N. Bolli, J. Chan, A. Dodero, C. Carniti, T.B. Heavican, A. Pellegrinelli, G. Pruneri, A. Butler, S.G. Bhosle, A. Chiappella, A. Di Rocco, P.L. Zinzani, F. Zaja, R. Piva, G. Inghirami, W. Wang, T. Palomero, J. Iqbal, A. Neri, P.J. Campbell, P. Corradini. - In: AMERICAN JOURNAL OF HEMATOLOGY. - ISSN 0361-8609. - 94:6(2019), pp. 628-634.
  • Maintenance Therapies for Hodgkin and Non-Hodgkin Lymphomas after Autologous Transplantation: A Consensus Project of ASBMT, CIBMTR, and the Lymphoma Working Party of EBMT / A.S. Kanate, A. Kumar, P. Dreger, M. Dreyling, S. Le Gouill, P. Corradini, C. Bredeson, T.S. Fenske, S.M. Smith, A. Sureda, A. Moskowitz, J.W. Friedberg, D.J. Inwards, A.F. Herrera, M.A. Kharfan-Dabaja, N. Reddy, S. Montoto, S.P. Robinson, S.A. Abutalib, C. Gisselbre, J. Vose, A. Gopal, M. Shadman, M. Perales, P. Carpenter, B.N. Savani, M. Hamadani. - In: JAMA ONCOLOGY. - ISSN 2374-2437. - (2019). [Epub ahead of print]
  • Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma / A. Dodero, A. Guidetti, A. Tucci, F. Barretta, M. Novo, L. Devizzi, A. Re, A. Passi, A. Pellegrinelli, G. Pruneri, R. Miceli, A. Testi, M. Pennisi, M.C. Di Chio, P. Matteucci, C. Carniti, F. Facchetti, G. Rossi, P. Corradini. - In: LEUKEMIA. - ISSN 0887-6924. - (2019).